ClinicalTrials.gov record
Terminated Phase 2 Interventional Results available

Study of Molecular Response in Adult Patients on Nilotinib With Philadelphia Chromosome Positive Chronic Myelogenous Leukemia (Ph+ CML) in Chronic Phase and a Suboptimal Molecular Response to Imatinib

ClinicalTrials.gov ID: NCT00644878

Public ClinicalTrials.gov record NCT00644878. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 16, 2026, 7:37 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Multi-center, Open-label, Exploratory Study of Bcr-Abl Kinetics in Adult Patients on Nilotinib With Philadelphia Chromosome Positive (Ph+) Chronic Myelogenous Leukemia in Chronic Phase (CML-CP) and a Suboptimal Molecular Response to Imatinib

Study identification

NCT ID
NCT00644878
Recruitment status
Terminated
Study type
Interventional
Phase
Phase 2
Lead sponsor
Novartis Pharmaceuticals
Industry
Enrollment
18 participants

Conditions and interventions

Interventions

  • Nilotinib Drug

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Sep 30, 2008
Primary completion
Feb 29, 2012
Completion
Feb 29, 2012
Last update posted
Aug 17, 2021

2008 – 2012

United States locations

U.S. sites
11
U.S. states
10
U.S. cities
11
Facility City State ZIP Site status
USC Norris Cancer Center Jane Anne Nohl Los Angeles California 90033
Georgia Health Sciences University Dept. of MCG Augusta Georgia 30912
Indiana Blood and Marrow Institute Beech Grove Indiana 46107
University of Iowa Hospitals & Clinics Univ of Iowa Hosp & Clinic Iowa City Iowa 52242
LSU HEALTH SCIENCES CENTER/ LSU SCHOOL OF MEDICINE Feist-Weiller Cancer Center New Orleans Louisiana 70115
St. Agnes Hospital Baltimore Maryland 21229
Cancer Centers of the Carolinas Greenville South Carolina 29615
South Texas Institute of Cancer Corpus Christi Texas 78405
Baylor College of Medicine - Breast Care Dan L Duncan Cancer Ctr Houston Texas 77030
Central Utah Clinic Central Utah Clinic (7) Provo Utah 84604
Froedert Memorial Lutheran Hospital Dept.ofFroedert Memorial Milwaukee Wisconsin 53226

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00644878, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Aug 17, 2021 · Synced May 16, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00644878 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →